Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Exelixis Inc
(NQ:
EXEL
)
26.03
+0.01 (+0.04%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Exelixis Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
2 Biotech Stocks to Buy Hand Over Fist in March
March 08, 2024
These stocks are worth buying in most months of the year.
Via
The Motley Fool
3 Cutting-Edge Biotech Stocks Sitting on the Brink of Success
March 06, 2024
With excellent financial health and great prospects, these three biotech stocks just may be the the next stars of the sector.
Via
InvestorPlace
In a market where value is scarce, NASDAQ:EXEL offers a refreshing opportunity with its solid fundamentals.
March 05, 2024
EXELIXIS INC (NASDAQ:EXEL) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
Via
Chartmill
4 Thrilling Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market
March 02, 2024
The growth-driven Nasdaq Composite has entered a new bull market, but plain-as-day deals can still be found.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Around $4M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying
February 23, 2024
Although U.S. stocks closed higher on Thursday, there were a few notable insider trades.
Via
Benzinga
2 Stocks Under $30 to Buy and Hold
February 19, 2024
You don't need to be a millionaire to get started. Investing on a budget can work, too.
Via
The Motley Fool
Recap: Exelixis Q4 Earnings
February 06, 2024
Via
Benzinga
Earnings Scheduled For February 6, 2024
February 06, 2024
Companies Reporting Before The Bell • BP (NYSE:BP) is projected to report quarterly earnings at $1.05 per share on revenue of $53.50 billion.
Via
Benzinga
Earnings Preview For Exelixis
February 05, 2024
Via
Benzinga
The 3 Best Biotech Stocks to Buy in February 2024
February 13, 2024
The best biotech stocks to buy offer consistent growth opportunities and resist the influence of singular drug successes.
Via
InvestorPlace
In a market where value is scarce, NASDAQ:EXEL offers a refreshing opportunity with its solid fundamentals.
February 13, 2024
For those who appreciate value investing, EXELIXIS INC (NASDAQ:EXEL) is a compelling option with its solid fundamentals.
Via
Chartmill
4 Appealing Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
February 10, 2024
The growth-driven Nasdaq Composite hasn't put the 2022 bear market entirely in the rearview mirror, which means opportunistic investors can still find bargains.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
3 Attractive Medical Stocks To Buy After Earnings
February 08, 2024
Quite a few top-rated stocks have highlighted this week’s earnings lineup with now appearing to be an ideal time to buy. Following their favorable quarterly results, here are 3 intriguing healthcare...
Via
Talk Markets
Exelixis (EXEL) Q4 2023 Earnings Call Transcript
February 06, 2024
EXEL earnings call for the period ending December 31, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
In the world of growth stocks, NASDAQ:EXEL shines as a value proposition.
February 05, 2024
NASDAQ:EXEL, a growth stock which is not overvalued.
Via
Chartmill
Breaking Down Exelixis: 7 Analysts Share Their Views
January 30, 2024
Via
Benzinga
NASDAQ:EXEL is showing good growth, while it is not too expensive.
December 21, 2023
Don't overlook EXELIXIS INC (NASDAQ:EXEL)—a stock with solid growth prospects and a reasonable valuation.
Via
Chartmill
6 Analysts Have This to Say About Exelixis
December 13, 2023
Via
Benzinga
Bristol Myers, Exelixis Reveal 4-Year Follow-Up Results From Cancer Treatment Study
January 23, 2024
Bristol Myers Squibb & Exelixis Inc revealed four-year follow-up results from CheckMate -9ER trial.
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
January 22, 2024
Via
Benzinga
3 Top-Rated Biotech Stocks Wall Street Analysts Are Loving Now: January 2024
January 21, 2024
These top-rated biotech stocks are going to be in high demand in January and in every other month in 2024.
Via
InvestorPlace
3 Pharma Stocks Could Be the Pills Your Portfolio Needs
January 18, 2024
These large-cap pharma stocks offer growth and value with existing medicines, deep pipelines and reasonable valuations.
Via
InvestorPlace
Stock Market Rally Rebounds; Nvidia, Tesla, JPMorgan, Bitcoin ETFs In Focus: Weekly Review
January 12, 2024
The major indexes and leading stocks rebounded. Bitcoin ETFs fell in their debut.
Via
Investor's Business Daily
Topics
ETFs
NASDAQ:EXEL, a growth stock which is not overvalued.
November 29, 2023
Investors seeking growth at a reasonable cost should explore NASDAQ:EXEL.
Via
Chartmill
Jim Cramer Likes This 'Well-Run' Airline, Says This Entertainment Stock Has 'Balance Sheet From Hell'
January 12, 2024
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Franco-Nevada Corporation (NYSE: FNV) is a "great diversified
Via
Benzinga
Don't overlook NASDAQ:EXEL—a stock with solid growth prospects and a reasonable valuation.
January 11, 2024
Investors should take note ofEXELIXIS INC (NASDAQ:EXEL), a growth stock that remains attractively priced.
Via
Chartmill
Why Is $7B Valued Cancer Focused Exelixis Trading Lower Today?
January 08, 2024
Sunday, Exelixis Inc (NASDAQ: EXEL) provided financial guidance for fiscal year 2024 and delivered an
Via
Benzinga
Regeneron Slumps As Its Biggest Moneymaker Falls Short; Exelixis Dives On Guidance Woes
January 08, 2024
Shares of both skidded early Monday as the annual J.P. Morgan Healthcare Conferenced kicked off In San Francisco.
Via
Investor's Business Daily
Under the Microscope: 3 Biotech Stocks Pioneering Tomorrow’s Cures
November 09, 2023
Unveil the resilience of biotech stocks as they outsmart market trends and champion the race for tomorrow's treatments.
Via
InvestorPlace
3 Biotech Stocks With the Strongest Clinical Pipelines
November 08, 2023
Many industry heavyweights are on the hunt for fresh new ideas -- great news for biotech stocks to buy with strong pipelines.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.